TY - JOUR
T1 - Body composition and age in African-American and Caucasian Women
T2 - Relationship to plasma leptin levels
AU - Perry, H. M.
AU - Morley, J. E.
AU - Horowitz, M.
AU - Kaiser, F. E.
AU - Miller, O. K.
AU - Wittert, G.
N1 - Funding Information:
From the Geriatric Research, Education Jnd Clinical Center. St. Louis Veterans Affairs Medical Centet: St. Louis Division of Geriatric Medicine. St. Louis University Medical School. St. Louis. MO: and Department of Medicine, University of Adelaide. Adelaide. Australia. Submitted November 8. 1996: accepted May 28. 1997. Supported in part by National Institute on Aging Grant No. ROlAG10436 and the Group Health Foundation. Address reprint requests to H.M. Perry III. MD. Division of Geriatrics. St. Louis University Medical School, 1402 S Grand Blvd. .44238. St. Louis MO 63104. Copyright © 1997 by W..B. Saunders Company 0026-0495/97/4612 -0005503.00/0
PY - 1997
Y1 - 1997
N2 - Leptin is a recently isolated peptide hormone released from adipocytes that has been postulated to play a role in appetite regulation end energy metabolism. Aging affects both food intake and body composition. Body composition is also affected by ethnicity. We have evaluated the relationships between Serum leptin levels, age, body composition (by dual- energy x-ray absorptiometry), and hormonal parameters in a cross-sectional study of 94 women, 53 African-American (AAF) and 41 Caucasian (CF). Our hypotheses were as follows: (1) changes in body composition would be related to age in a sinusoidal pattern, (2) changes in serum leptin would parallel changes in body fat, (3) serum leptin levels would be influenced by body fat distribution, and (4) serum leptin would be related to serum concentrations of sex hormones. Serum leptin paralleled changes in body fat and body mass index (BMI) with age. In the entire group, serum leptin correlated closely with measures of body fat, including BMI and total fat mass, and there was no difference in leptin levels between the two ethnic groups. In simple regression analysis, serum leptin was related to both serum estradiol and testosterone. The relationship between serum leptin and trunk fat was linear in both groups, but significantly different in AAF and CF (P = .014). Serum leptin was associated with the trunk to lower-extremity fat ratio in CF (r = .67, P = .001) but not in AAF. Body fat was increased with advancing age until about 65 years and then declined. Measures of lean body mass declined linearly with age in the entire group, as well as both subgroups. In the entire group, total lean body mass and lean body mass corrected for BMI (lean body mass/BMI) were inversely related to age. In subjects aged less then 60 years AAF were stronger (P < .05) and had both a larger BMI and fat mass (P < .05) than CF. However, the patterns of age-related changes in fat body mass, lean body mass, and BMI were similar in both groups. In the entire group, multiple regression analysis indicated that the age, free thyroxine index (FTI), and leptin concentration were predictors of the body composition and distribution of trunk to lower-body fat. These observations indicate that there is a sinusoidal relationship between body fat and age, with a decline in body fat in extreme old age in both AAF and CF, and that serum leptin concentrations are more closely related to body fat and BMI than to age or ethnicity.
AB - Leptin is a recently isolated peptide hormone released from adipocytes that has been postulated to play a role in appetite regulation end energy metabolism. Aging affects both food intake and body composition. Body composition is also affected by ethnicity. We have evaluated the relationships between Serum leptin levels, age, body composition (by dual- energy x-ray absorptiometry), and hormonal parameters in a cross-sectional study of 94 women, 53 African-American (AAF) and 41 Caucasian (CF). Our hypotheses were as follows: (1) changes in body composition would be related to age in a sinusoidal pattern, (2) changes in serum leptin would parallel changes in body fat, (3) serum leptin levels would be influenced by body fat distribution, and (4) serum leptin would be related to serum concentrations of sex hormones. Serum leptin paralleled changes in body fat and body mass index (BMI) with age. In the entire group, serum leptin correlated closely with measures of body fat, including BMI and total fat mass, and there was no difference in leptin levels between the two ethnic groups. In simple regression analysis, serum leptin was related to both serum estradiol and testosterone. The relationship between serum leptin and trunk fat was linear in both groups, but significantly different in AAF and CF (P = .014). Serum leptin was associated with the trunk to lower-extremity fat ratio in CF (r = .67, P = .001) but not in AAF. Body fat was increased with advancing age until about 65 years and then declined. Measures of lean body mass declined linearly with age in the entire group, as well as both subgroups. In the entire group, total lean body mass and lean body mass corrected for BMI (lean body mass/BMI) were inversely related to age. In subjects aged less then 60 years AAF were stronger (P < .05) and had both a larger BMI and fat mass (P < .05) than CF. However, the patterns of age-related changes in fat body mass, lean body mass, and BMI were similar in both groups. In the entire group, multiple regression analysis indicated that the age, free thyroxine index (FTI), and leptin concentration were predictors of the body composition and distribution of trunk to lower-body fat. These observations indicate that there is a sinusoidal relationship between body fat and age, with a decline in body fat in extreme old age in both AAF and CF, and that serum leptin concentrations are more closely related to body fat and BMI than to age or ethnicity.
UR - http://www.scopus.com/inward/record.url?scp=0031464354&partnerID=8YFLogxK
U2 - 10.1016/S0026-0495(97)90138-4
DO - 10.1016/S0026-0495(97)90138-4
M3 - Article
C2 - 9439533
AN - SCOPUS:0031464354
SN - 0026-0495
VL - 46
SP - 1399
EP - 1405
JO - Metabolism: Clinical and Experimental
JF - Metabolism: Clinical and Experimental
IS - 12
ER -